India VIX, a measure of traders' perception of near-term market risks, which had surged 7.8% yesterday was now down 5.3% at 14.47.
At 2:15PM, the 30-share Sensex was up 240 points at 21,187 and Nifty was up 69 points at 6,291.
Also Read
Market breadth was positive with 1,443 gainers and 1,062 losers on the BSE.
Asian shares also firmed up hopes of a possible peaceful solution in Ukraine. Asian markets except for China which had slumped yesterday were trading higher. Japan's benchmark Nikkei ended up on value buying after recent correction. The index ended up 0.5% while Straits Times and Hang Seng were each trading 0.7% higher. However, Shanghai COmposite which had gained yesterday witnessed profit taking at higher levels and was down 0.2%.
Shares in Europe also traded higher on hopes that geopolitical tensions in Ukraine may subside going forward. The CAC-40, DAX and FTSE were up over 1% each.
Meanwhile, global oil and gold prices also eased around 1% after tensions in Ukraine were seen subsiding.
BSE Metal index was the top sectoral gainer on the BSE up 2.5% followed by Bankex, Capital Goods, Power, Oil and Gas indices among others.
Banks were among the top gainers with ICICI Bank, Axis Bank, HDFC and SBI up 1-3.5% each.
In the capital goods space BHEL was up nearly 3% after Life Insurance Corporation has bought shares worth Rs 1,889 crore, about 4.66% stake, in state-owned power equipment maker BHEL through an open market transaction. LIC has purchased 11.41 crore shares in BHEL at a price of Rs 165.55 apiece through a block deal on the BSE. L&T was up 2%.
FMCG majors ITC and Hindustan Unilever were both up 1-2% each while index heavyweight Reliance Ind was up 1.2%.
Other Sensex gainers include, Sesa Sterlite, ONGC, Hindalco and Tata Motors among others.
Among other shares, GlaxoSmithKline Pharma (GSK) is trading lower by 3% at Rs 2,969, in otherwise firm market, ahead of closure of the open offer made by the Britain-based parent company to acquire additional stake in Indian arm tomorrow. The London listed parent of GSK - GlaxoSmithKline Plc -which holds currently 50.67% stake in the Indian company, is aiming to invest Rs 6,390 crore to acquire stake in Indian company. The public shareholders held total 41.78 million or 49.33% stake in the pharmaceutical company.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)